12-21437623-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000543476.5(PYROXD1):c.-108A>C variant causes a 5 prime UTR, NMD transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.53 in 1,070,330 control chromosomes in the GnomAD database, including 151,111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.52 ( 20742 hom., cov: 32)
Exomes 𝑓: 0.53 ( 130369 hom. )
Consequence
PYROXD1
ENST00000543476.5 5_prime_UTR, NMD_transcript
ENST00000543476.5 5_prime_UTR, NMD_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.105
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 12-21437623-A-C is Benign according to our data. Variant chr12-21437623-A-C is described in ClinVar as [Benign]. Clinvar id is 1228725.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PYROXD1 | NM_024854.5 | upstream_gene_variant | ENST00000240651.14 | ||||
PYROXD1 | NM_001350913.2 | upstream_gene_variant | |||||
PYROXD1 | XM_006719153.4 | upstream_gene_variant | |||||
PYROXD1 | XM_047429554.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PYROXD1 | ENST00000543476.5 | c.-108A>C | 5_prime_UTR_variant, NMD_transcript_variant | 1/9 | 5 | ||||
PYROXD1 | ENST00000240651.14 | upstream_gene_variant | 1 | NM_024854.5 | P1 | ||||
PYROXD1 | ENST00000375266.8 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.522 AC: 79271AN: 151918Hom.: 20722 Cov.: 32
GnomAD3 genomes
AF:
AC:
79271
AN:
151918
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.532 AC: 488416AN: 918294Hom.: 130369 Cov.: 12 AF XY: 0.529 AC XY: 249257AN XY: 471618
GnomAD4 exome
AF:
AC:
488416
AN:
918294
Hom.:
Cov.:
12
AF XY:
AC XY:
249257
AN XY:
471618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.522 AC: 79337AN: 152036Hom.: 20742 Cov.: 32 AF XY: 0.520 AC XY: 38669AN XY: 74298
GnomAD4 genome
AF:
AC:
79337
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
38669
AN XY:
74298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1946
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at